News

HHS Secretary Robert F. Kennedy Jr. announced that he has unilaterally struck the recommendation that healthy children and ...
The decision to scale back recommendations has raised concerns about insurance coverage and future access to COVID vaccines.
After a six-week delay, the US Food and Drug Administration has approved Novavax’s Covid-19 vaccine, according to a letter ...
Presented by The Coalition to Strengthen America’s Healthcare{beacon} Health Care Health Care   The Big Story RFK Jr. ends ...
This vaccine did previously have emergency approval by the FDA for use but can now be marketed in the U.S. for use, the ...
A group of experts who advise the US Food and Drug Administration on its vaccine decisions voted unanimously Thursday to make ...
The FDA has approved the Novavax COVID-19 vaccine, called Nuvaxovid, mainly for adults 65 or older, but people ages 12 to 64 ...
The agency narrowed who can get the shot and added new study requirements that could cost the company tens of millions.
The FDA is implementing stricter guidance for the approval of COVID-19 vaccines, according to a paper published in The New England Journal of Medicine.